Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dubourg, G., Lagier, J. C., Armougom, F., Robert, C., Hamad, I., Brouqui, P., & Raoult, D. (2013). The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, 32(5), 637–645.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: clinical sources (blood, sputum - CCUG) and human faeces (including ulcerative colitis patients)
DNA G+C(%): 49.7-60.6
|
Opt. T: 28-30℃
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R(MIC50): >8, MIC90: >8, RNG: (4->8)
Augmentin: Var(MIC50): 4, MIC90: >16, RNG: (0.5–>16)
ampicillin: Res
carbenicil: Sens
penicillin: R(5U)
penicillin_G: R(MIC50): >16, MIC90: >16, RNG: (16–>16)
piper-taz: S(≤1/4)
ertapenem: S(≤0.125/≤0.125)
imipenem: S(MIC50): 1, MIC90: 2, RNG: (≤1-2)
meropenem: S(MIC50): -, MIC90: 0.12
|
cefamandole: Sens
cefepime: RNG: (7.81-)
cefoxitin: Sens
ceftazidime: Var(MIC50): 0.5, MIC90: 8, RNG: (0.12->8)
cefuroxime: Var(MIC50): 4, MIC90: >32, RNG: (0.5–>32)
cephalothin: Res
|
amikacin: S(MIC50): ≤2, MIC90: ≤2, RNG: (1-8)
gentamicin: S(MIC50): 1, MIC90: 2, RNG: (≤1->4)
kanamycin: S(30)
neomycin: S(10)
netilmycin: SensRNG: (0.25-2)
sisomicin: SensRNG: (0.125-1)
streptomycin: S(25)
tobramycin: SensRNG: (0.25-1)
|
erythromycin: R(10)
|
ciprofloxacin: S(MIC50): 0.03, MIC90: 0.06, RNG: (≤0.03-0.06)
gatifloxacin: S(MIC50): 0.03, MIC90: 0.06, RNG: (<0.008-0.12)
levofloxacin: S(MIC50): 0.03, MIC90: 0.06, RNG: (0.015-0.06)
moxifloxacin: S(MIC50): 0.06, MIC90: 0.12, RNG: (0.015-0.12)
trovafloxacin: S(MIC50): 0.03, MIC90: 0.06, RNG: (≤0.03-0.12)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
minocycline: S(MIC50): 0.5, MIC90: 2, RNG: (0.25-4)
tetracycline: S(MIC50): 1, MIC90: 2, RNG: (0.5-2)
tigecycline: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.12-1)
|
|
|
chloramphenicol: S(50)
nitrofurantoin: S(200)
sulfamethoxazole: S(200)
co-trimoxazole: S(MIC50): ≤0.5, MIC90: ≤0.5, RNG: (≤0.5-)
|
clindamycin: S(MIC50): 0.008, MIC90: 0.015, RNG: (0.008-0.06)
|